[1]
T. Dilla, L. Prieto, A. Ciudad, and J. A. Sacristán, “Economic analyses of olanzapine in the treatment of schizophrenia and bipolar disorder”, Actas Esp Psiquiatr, vol. 32, no. 5, pp. 269–279, Sep. 2004.